Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07591558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.
Trial Details
NCT Number NCT07591558
Lead Sponsor King Abdullah University Hospital
Collaborators: Jordan University of Science and Technology
Conditions
(from sponsor)
Atelectases, Postoperative Pulmonary, Diabete Mellitus
Related terms Diabetes Mellitus, Pulmonary Atelectasis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov